Womb cancer deaths rise by a fifth in the last decade

April 5, 2012

(Medical Xpress) -- Deaths from womb (uterine) cancer have risen by nearly twenty per cent in the last decade, according to new figures from Cancer Research UK today.

Since the late 1990s, the mortality rate has risen from 3.1 to 3.7 per 100,000 in the UK. This means more than 1,900 women are now dying from the disease each year, compared to fewer than 1,500 at the turn of the millennium.

But from continue to improve – with 77 per cent of women now surviving their disease five years or more.

The rise in deaths follows a steep increase in the number of women being diagnosed with womb cancer, with incidence rising by 43 per cent since the mid 1990s, from 13.7 to 19.6 per 100,000.

Prior to this, incidence of womb cancer had been constant for at least 25 years, and mortality had been declining.

Obesity at least doubles the risk of womb cancer, and has been linked to many other cancer types, leading experts to believe it could be a key factor driving up incidence.

So although survival from womb cancer continues to improve gradually, more women are in fact dying from the disease, because of the recent rise in numbers of women being diagnosed.

Professor Jonathan Ledermann, Cancer Research UK's gynaecological cancer expert, said: “It’s hugely troubling that more women are dying from womb cancer, but we shouldn’t let this cloud the fact that the chances of surviving the disease are still better than ever. This is due to better organisation of care for women’s cancers and more widespread use of one-stop clinics for post-menopausal bleeding, as well as advances in the use of surgery, chemotherapy and radiotherapy through clinical trials. It’s clear we’re making great progress, but we don’t yet fully understand what’s driving up cases of womb cancer, so there’s still lots more to do.”

Londoner Sharon Robinson, 56, who is a womb cancer survivor, said: “When I first had bleeding I thought it might be something to do with the menopause, but then it became more serious and I went to my doctor. Being told I had cancer was terrifying, as I knew it meant having my womb removed followed by weeks of radiotherapy. But in the end it was all worth it because here I am today cancer free. It’s so important that women who have symptoms like bleeding after the menopause go to their doctor without delay, as spotting cancer early save lives.”

Sara Hiom, director of information at Cancer Research UK, said: “Despite survival rates continuing to improve, these worrying figures show more women are still dying from womb cancer. This appears to be related to a rise in the incidence of womb cancer, so it’s essential women receive support to help them reduce their risk.

“Maintaining a healthy bodyweight can halve a woman’s risk of womb cancer and is one of the best ways to protect against the disease. Women should also be aware of the symptoms of womb cancer which include abnormal vaginal bleeding – especially for post-menopausal - abdominal pain and pain during sex.

“Although these symptoms don’t usually mean cancer, as they could be signs of more common conditions like fibroids or endometriosis, it’s still vital to get them checked by a doctor. The earlier the disease is diagnosed, the more likely treatment will be successful.”

Explore further: Bowel cancer risk doubles for men

Related Stories

Bowel cancer risk doubles for men

July 27, 2011

Men’s chances of getting bowel cancer in Great Britain have doubled since the mid 70s - according to new figures released today by Cancer Research UK.

Cancer is the biggest premature killer

November 3, 2011

Cancer is responsible for killing 40 per cent of all the men and women who die prematurely between the ages of 25 and 74 in the UK – according to a new analysis of the figures released today by Cancer Research UK.

Recommended for you

Combination therapy can prevent cytostatic resistance

November 26, 2015

Researchers at Karolinska Institutet have found a new way of preventing resistance to cytostatics used in the treatment of cancers such as medulloblastoma, the most common form of malignant brain tumour in children. The promising ...

Forecasting the path of breast cancer in a patient

November 23, 2015

USC researchers have developed a mathematical model to forecast metastatic breast cancer survival rates using techniques usually reserved for weather prediction, financial forecasting and surfing the Web.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.